MPO inhibition in microvesicles.

JP Johanne Poisson
MT Marion Tanguy
HD Hortense Davy
FC Fatoumata Camara
MM Marie-Belle El Mdawar
MK Marouane Kheloufi
TD Tracy Dagher
CD Cécile Devue
JL Juliette Lasselin
AP Aurélie Plessier
SM Salma Merchant
OB Olivier Blanc-Brude
MS Michèle Souyri
NM Nathalie Mougenot
FD Florent Dingli
DL Damarys Loew
SH Stephane N. Hatem
CJ Chloé James
JV Jean-Luc Villeval
CB Chantal M. Boulanger
PR Pierre-Emmanuel Rautou
request Request a Protocol
ask Ask a question
Favorite

Erythrocyte-derived microvesicles from Jak2V617F HC-EC mice were incubated for 1 hour with an irreversible MPO inhibitor (MPOi, PF06281355, resuspended in DMSO, Sigma-Aldrich) diluted in PBS (5 mol/L final concentration). Then, the same amount of annexin V–positive erythrocyte-derived microvesicles (JAK2WT, JAK2V617F, and JAK2V617F with MPOi) were washed in PBS and centrifuged at 20,500 g for 2 hours. The pellet containing the microvesicles was then resuspended in endothelial cell basic medium (PromoCell). HUVECs (single donor; PromoCell, C-12200, lot 445Z011) were then incubated for 2 hours at 37°C with these microvesicles. At the end of the incubation, and without washing cells, ROS generation was assessed using CellROX, as described above. After rinsing with medium and paraformaldehyde (4%, 5 minutes), HUVECs were costained with DAPI (0.1 μg/mL, Sigma-Aldrich) in order to identify nuclei. Images were acquired using a Leica SP8 confocal microscope at ×400 magnification.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A